Eversept Partners, LP
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | $2,650,965,000 | Pooled investment vehicles (99%) |
| Apr 2025 to Mar 2026 | $1,742,083,000 | Pooled investment vehicles (100%) |
| Apr 2024 to Mar 2025 | $1,482,568,000 | Pooled investment vehicles (100%) |
| May 2023 to Mar 2024 | $1,671,022,000 | Pooled investment vehicles (100%) |
| Apr 2023 | $1,671,022,000 | Pooled investment vehicles (100%) |
| Apr 2022 to Mar 2023 | $1,842,319,563 | Pooled investment vehicles (100%) |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 95.8%; sector active share 88.7% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
119 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 90.3% | $1,741,560,444 |
| Real Estate | 5.6% | $107,691,659 |
| Unclassified | 4.0% | $77,514,790 |
| Financial Services | 0.0% | $872,173 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| EHC | Encompass Health Corp | +832,815 | 1,026,919 | $103,800,972 | |
| ENSG | Ensign Group, Inc | +587,318 | 602,079 | $96,513,263 | |
| CTMX | CytomX Therapeutics, Inc. | +369,983 | 3,558,497 | $13,344,363 | |
| VKTX | Viking Therapeutics, Inc. | +363,812 | 602,922 | $23,519,987 | |
| TVTX | Travere Therapeutics, Inc. | +256,363 | 798,973 | $45,389,656 | |
| REPL | Replimune Group, Inc. | +255,391 | 590,252 | $6,534,089 | |
| SPRY | ARS Pharmaceuticals, Inc. | +240,772 | 377,007 | $3,019,826 | |
| EHTH | eHealth, Inc. | +183,939 | 404,854 | $603,232 | |
| EDIT | Editas Medicine, Inc. | +167,890 | 458,809 | $1,486,541 | |
| RLAY | Relay Therapeutics, Inc. | +163,609 | 434,314 | $8,126,014 | |
| PNTG | Pennant Group, Inc. | +148,094 | 460,272 | $17,007,050 | |
| EVMN | Evommune, Inc. | +119,780 | 174,460 | $2,318,573 | |
| VRDN | Viridian Therapeutics, Inc.\DE | +117,873 | 831,142 | $15,268,078 | |
| LTC | Ltc Properties Inc | +99,594 | 420,640 | $16,173,608 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +91,555 | 154,130 | $5,146,400 | |
| THC | Tenet Healthcare Corp | +84,687 | 114,199 | $21,364,348 | |
| LBRX | Lb Pharmaceuticals Inc | +83,465 | 183,663 | $5,960,782 | |
| SNDA | Sonida Senior Living, Inc. | +74,187 | 102,624 | $4,187,059 | |
| ALEC | Alector, Inc. | +72,767 | 1,423,873 | $2,861,984 | |
| XENE | Xenon Pharmaceuticals Inc. | +66,958 | 196,532 | $11,862,671 | |
| BRKR | Bruker Corp | +65,881 | 182,894 | $11,006,560 | |
| GPCR | Structure Therapeutics Inc. | +58,266 | 196,302 | $10,535,528 | |
| DFTX | Definium Therapeutics, Inc. | +56,462 | 217,185 | $10,216,382 | |
| MOH | Molina Healthcare, Inc. | +47,783 | 80,594 | $18,431,847 | |
| ANAB | Anaptysbio, Inc | +42,894 | 69,983 | $4,723,852 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GSK | GSK plc | −1,303,342 | 481,833 | $25,257,685 | |
| BCRX | Biocryst Pharmaceuticals Inc | −1,174,167 | 1,865,653 | $18,656,530 | |
| CYH | Community Health Systems Inc | −812,706 | 7,864,575 | $26,267,680 | |
| PALI | Palisade Bio, Inc. | −804,714 | 4,182,785 | $8,742,020 | |
| ARDX | Ardelyx, Inc. | −551,101 | 1,678,345 | $8,559,559 | |
| PMVP | PMV Pharmaceuticals, Inc. | −457,456 | 1,890,904 | $2,533,811 | |
| IFRX | InflaRx N.V. | −454,504 | 1,304,069 | $2,921,114 | |
| ARQT | Arcutis Biotherapeutics, Inc. | −441,225 | 135,355 | $3,549,008 | |
| PCVX | Vaxcyte, Inc. | −294,241 | 629,952 | $36,619,109 | |
| LQDA | Liquidia Corp | −248,740 | 428,652 | $34,176,423 | |
| AVR | Anteris Technologies Global Corp. | −234,958 | 166,229 | $1,637,355 | |
| NTRA | Natera, Inc. | −208,906 | 175,807 | $47,722,810 | |
| RLMD | Relmada Therapeutics, Inc. | −184,707 | 93,192 | $644,888 | |
| SVRA | Savara Inc | −179,836 | 204,428 | $1,259,276 | |
| BKD | Brookdale Senior Living Inc. | −172,085 | 3,396,470 | $54,649,202 | |
| BBNX | Beta Bionics, Inc. | −165,397 | 1,249,441 | $19,578,740 | |
| AGL | agilon health, inc. | −138,796 | 37,792 | $4,050,546 | |
| GERN | Geron Corp | −117,461 | 18,717,422 | $23,958,300 | |
| TECH | BIO-TECHNE Corp | −106,588 | 19,308 | $1,364,110 | |
| RGEN | Repligen Corp | −106,384 | 14,401 | $1,964,872 | |
| OHI | Omega Healthcare Investors Inc | −102,133 | 483,547 | $23,055,520 | |
| WELL | Welltower Inc. | −93,641 | 87,312 | $19,817,204 | |
| VIR | Vir Biotechnology, Inc. | −93,364 | 156,636 | $1,596,120 | |
| SNDX | Syndax Pharmaceuticals Inc | −87,412 | 2,798,210 | $61,168,870 | |
| ENGN | enGene Therapeutics Inc. | −40,959 | 469,584 | $812,380 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CTRE | CareTrust REIT, Inc. | 1,072,015 | $43,255,805 | |
| UNH | Unitedhealth Group Inc | 51,145 | $21,257,396 | |
| COGT | Cogent Biosciences, Inc. | 490,235 | $18,972,094 | |
| INSM | INSMED Inc | 149,209 | $15,908,663 | |
| AMN | Amn Healthcare Services Inc | 428,531 | $13,871,548 | |
| CELC | Celcuity Inc. | 127,931 | $13,384,141 | |
| HUM | Humana Inc | 31,171 | $12,381,744 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 747,994 | $11,175,030 | |
| ASND | Ascendis Pharma A/S | 41,621 | $11,101,153 | |
| MLYS | Mineralys Therapeutics, Inc. | 309,689 | $8,355,409 | |
| NVO | Novo Nordisk A S | 169,227 | $8,112,742 | |
| BHVN | Biohaven Ltd. | 515,804 | $7,675,163 | |
| PTGX | Protagonist Therapeutics, Inc | 58,504 | $7,171,420 | |
| ELVN | Enliven Therapeutics, Inc. | 136,631 | $6,934,023 | |
| BEAM | Beam Therapeutics Inc. | 166,289 | $5,707,038 | |
| NHI | National Health Investors Inc | 70,673 | $5,389,522 | |
| PACS | PACS Group, Inc. | 117,441 | $5,007,684 | |
| NHC | National Healthcare Corp | 22,116 | $4,674,437 | |
| EYPT | EyePoint, Inc. | 297,735 | $4,257,610 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 55,710 | $3,506,387 | |
| VOR | Vor Biopharma Inc. | 149,681 | $2,755,627 | |
| DSGN | Design Therapeutics, Inc. | 190,000 | $2,749,300 | |
| SPRB | Spruce Biosciences, Inc. | 40,000 | $2,160,000 | |
| PRQR | ProQR Therapeutics N.V. | 1,022,265 | $1,901,412 | |
| RVMD | Revolution Medicines, Inc. | 6,943 | $1,300,285 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DOC | Healthpeak Properties, Inc. | 1,981,070 | $32,548,980 | |
| AVTR | Avantor, Inc. | 2,974,287 | $23,318,410 | |
| QGEN | Qiagen N.V. | 545,330 | $21,835,013 | |
| ICLR | Icon PLC | 68,688 | $7,601,014 | |
| AGIO | Agios Pharmaceuticals, Inc. | 200,000 | $6,766,000 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 10,000 | $5,234,700 | |
| — | 1,735,963 | $4,756,539 | ||
| HQY | Healthequity, Inc. | 51,614 | $4,313,381 | |
| — | 183,902 | $3,942,859 | ||
| CNC | Centene Corp | 111,652 | $3,655,486 | |
| — | 227,451 | $3,204,785 | ||
| STRO | Sutro Biopharma, Inc. | 73,161 | $1,822,440 | |
| NVCR | NovoCure Ltd | 134,917 | $1,470,595 | |
| BVS | Bioventus Inc. | 159,110 | $1,452,674 | |
| IMCR | Immunocore Holdings plc | 39,238 | $1,183,025 | |
| TYRA | Tyra Biosciences, Inc. | 27,055 | $1,036,206 | |
| PASG | Passage BIO, Inc. | 131,581 | $1,032,910 | |
| DHC | Diversified Healthcare Trust | 151,283 | $1,004,519 | |
| INMD | InMode Ltd. | 67,744 | $926,737 | |
| AIRS | Airsculpt Technologies, Inc. | 74,139 | $209,813 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 287,668 | $155,867,152 | 8.09% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 913,880 | $121,783,648 | 6.32% | |
| EHC |
Encompass Health Corp
Healthcare
|
Added | 1,026,919 | $103,800,972 | 5.38% | |
| ENSG |
Ensign Group, Inc
Healthcare
|
Added | 602,079 | $96,513,263 | 5.01% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 2,212,770 | $94,949,960 | 4.93% | |
| QQQ |
Invesco Qqq Trust, Series 1
PUT
|
Reduced | 98,600 | $72,609,040 | 3.77% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 1,785,941 | $66,454,864 | 3.45% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 2,798,210 | $61,168,870 | 3.17% | |
| BKD |
Brookdale Senior Living Inc.
Healthcare
|
Reduced | 3,396,470 | $54,649,202 | 2.84% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 664,684 | $52,702,794 | 2.73% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 175,807 | $47,722,810 | 2.48% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 798,973 | $45,389,656 | 2.35% | |
| CTRE |
CareTrust REIT, Inc.
Real Estate
|
NEW | 1,072,015 | $43,255,805 | 2.24% | |
| HCA |
HCA Healthcare, Inc.
Healthcare
|
Added | 98,252 | $38,307,472 | 1.99% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 629,952 | $36,619,109 | 1.90% | |
| LQDA |
Liquidia Corp
Healthcare
|
Reduced | 428,652 | $34,176,423 | 1.77% | |
| CYH |
Community Health Systems Inc
Healthcare
|
Reduced | 7,864,575 | $26,267,680 | 1.36% | |
| INSM |
INSMED Inc
CALL
+ SHARES
Healthcare
|
Added | 245,809 | $26,208,155 | 1.36% | |
| GSK |
GSK plc
Healthcare
|
Reduced | 481,833 | $25,257,685 | 1.31% | |
| CHE |
Chemed Corp
Healthcare
|
Added | 52,523 | $24,462,062 | 1.27% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 20,116 | $24,127,735 | 1.25% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 18,717,422 | $23,958,300 | 1.24% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Added | 602,922 | $23,519,987 | 1.22% | |
| OHI |
Omega Healthcare Investors Inc
Real Estate
|
Reduced | 483,547 | $23,055,520 | 1.20% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 148,816 | $22,657,236 | 1.18% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Added | 114,199 | $21,364,348 | 1.11% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 51,145 | $21,257,396 | 1.10% | |
| WELL |
Welltower Inc.
Real Estate
|
Reduced | 87,312 | $19,817,204 | 1.03% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Reduced | 1,249,441 | $19,578,740 | 1.02% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 490,235 | $18,972,094 | 0.98% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 1,865,653 | $18,656,530 | 0.97% | |
| MOH |
Molina Healthcare, Inc.
Healthcare
|
Added | 80,594 | $18,431,847 | 0.96% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
Added | 460,272 | $17,007,050 | 0.88% | |
| LTC |
Ltc Properties Inc
Real Estate
|
Added | 420,640 | $16,173,608 | 0.84% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 831,142 | $15,268,078 | 0.79% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 249,607 | $14,282,512 | 0.74% | |
| AMN |
Amn Healthcare Services Inc
Healthcare
|
NEW | 428,531 | $13,871,548 | 0.72% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 127,931 | $13,384,141 | 0.69% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 386,383 | $13,361,124 | 0.69% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 3,558,497 | $13,344,363 | 0.69% | |
| HUM |
Humana Inc
Healthcare
|
NEW | 31,171 | $12,381,744 | 0.64% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 196,532 | $11,862,671 | 0.62% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 747,994 | $11,175,030 | 0.58% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
NEW | 41,621 | $11,101,153 | 0.58% | |
| BRKR |
Bruker Corp
Healthcare
|
Added | 182,894 | $11,006,560 | 0.57% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 152,122 | $10,653,103 | 0.55% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 196,302 | $10,535,528 | 0.55% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
Added | 217,185 | $10,216,382 | 0.53% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Reduced | 672,825 | $9,520,473 | 0.49% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 275,471 | $9,335,712 | 0.48% |
Showing the top 50 of 119 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.